Embedded Files
IMARC Group’s report titled “Prefilled Syringes Market Report by Design (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, Customized Prefilled Syringes), Material (Glass Prefilled Syringes, Plastic Prefilled Syringes), Closing System (Staked Needle System, Luer Cone System, Luer Lock Form System), Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis, Oncology, and Others), End User (Hospitals, Clinics, and Others), and Region 2024-2032”. The global prefilled syringes market size reached US$ 7.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032.
Grab a sample PDF of this report: https://www.imarcgroup.com/prefilled-syringes-market/requestsample
Factors Affecting the Growth of the Prefilled Syringes Industry:
Increasing Prevalence of Chronic Diseases:
The rising incidence of chronic diseases, such as diabetes, cardiovascular diseases, and autoimmune disorders is impelling the growth of the market. These conditions often require regular and precise medication administration, which prefilled syringes can provide. Prefilled syringes offer a convenient, ready-to-use solution that enhances patient adherence to prescribed therapies, ensuring better disease management. Moreover, diabetic patients frequently need insulin injections, and prefilled syringes reduce the complexity and time involved in drawing the medication from vials. This ease of use is crucial for patients who require lifelong treatment and can significantly improve their quality of life.
Advancements in Biotechnology and Pharmaceuticals:
Technological advancements in biotechnology and pharmaceuticals are propelling the of the market growth. Innovations in drug formulation and delivery systems are leading to the development of biologics and biosimilars that are often administered via injection. Prefilled syringes are particularly suited for these complex medications as they ensure the stability and integrity of the drug until administration. Furthermore, advancements in syringe design, such as the incorporation of safety features to prevent needlestick injuries, are increasing their acceptance among healthcare professionals. The development of prefilled syringes with integrated auto-injectors or needle-free systems also caters to the needs of patients for convenience and ease of use.
Growing Demand for Home-Based Healthcare:
The shift towards home-based healthcare is supporting the market growth. With the increasing preference for home care due to its cost-effectiveness and convenience, there is a high demand for medical devices that can be easily used outside of traditional healthcare settings. Prefilled syringes fit this requirement perfectly as they are designed for simplicity and ease of use, enabling patients or caregivers to administer medications safely and accurately at home. This trend is particularly prominent in the management of chronic diseases, where frequent hospital visits can be burdensome and costly. Home-based administration of medications using prefilled syringes reduces the need for regular clinical visits, thereby decreasing healthcare costs and enhancing patient comfort.
Leading Companies Operating in the Global Prefilled Syringes Industry:
Abbott Laboratories
B. Braun Melsungen AG
Baxter International Inc.
Bayer AG
Becton Dickinson and Company
Cardinal Health Inc.
Catalent Inc.
Fresenius SE & Co. KGaA
Gerresheimer AG
Nipro Corporation
Schott AG
Terumo Corporation
West Pharmaceutical Services Inc.
Prefilled Syringes Market Report Segmentation:
By Design:
Single-chamber Prefilled Syringes
Dual-chamber Prefilled Syringes
Customized Prefilled Syringes
Single-chamber prefilled syringes represent the largest segment due to their simplicity, cost-effectiveness, and widespread use in administering a variety of medications.
By Material:
Glass Prefilled Syringes
Plastic Prefilled Syringes
Glass prefilled syringes account for the majority of the market share owing to their excellent chemical resistance and drug compatibility, ensuring the stability and integrity of medications.
By Closing System:
Staked Needle System
Luer Cone System
Luer Lock Form System
Staked needle system holds the biggest market share because they minimize drug wastage and reduce the risk of needlestick injuries, enhancing both safety and efficiency.
By Application:
Diabetes
Anaphylaxis
Rheumatoid Arthritis
Oncology
Others
Based on the application, the market has been divided into diabetes, anaphylaxis, rheumatoid arthritis, oncology, and others.
By End User:
Hospitals
Clinics
Others
Hospitals represent the leading segment driven by the high volume of medical procedures and the need for reliable and efficient drug delivery methods.
Regional Insights:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Europe's dominance in the prefilled syringes market is attributed to its advanced healthcare infrastructure, strong regulatory support, and high adoption rates of innovative medical technologies.
Global Prefilled Syringes Market Trends:
The emphasis on patient safety and compliance is bolstering the market growth. Traditional methods of drug administration, such as vials and ampoules, often require multiple steps, increasing the risk of dosing errors and contamination. Prefilled syringes, on the other hand, come preloaded with the exact dosage, reducing the likelihood of these issues and ensuring that patients receive the correct amount of medication. This aspect is particularly crucial for drugs with narrow therapeutic windows, where precise dosing is imperative to avoid adverse effects. Moreover, the design of prefilled syringes, often incorporating features like needle shields and tamper-evident seals, enhances safety by preventing accidental needlesticks and ensuring the sterility of the drug. These safety features not only protect patients but also healthcare providers, fostering a safer healthcare environment and promoting adherence to treatment protocols.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Page updated
Google Sites
Report abuse